SCLC Second-Line Treatment: Lurbinectedin vs Tarlatamab - Small Cell Lung Cancer OncInsights 2025-26 скачать в хорошем качестве

SCLC Second-Line Treatment: Lurbinectedin vs Tarlatamab - Small Cell Lung Cancer OncInsights 2025-26

In this video series that was recorded in November 2025, leading oncologists present patients and caregivers with the most current and emerging treatment information in small cell lung cancer, delivered in a concise and easy-to-understand format. In this video, Dr. Rodriguez summarizes what lurbinectedin and tarlatamab do and don't have in common as second-line treatments for small cell lung cancer (SCLC) and who are the best patients for these treatments. She also summarizes her entire presentation on treatment beyond progression for small cell lung cancer (SCLC). View transcript here: https://drive.google.com/file/d/137CD... Thank you to our Sponsors! Merck #genentech #daiichisankyo Catalyst Music: Ester - Here (BenSound) License: 2242649 For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. To follow along with this video using the YouTube transcript, click “Show transcript” at the bottom of the YouTube description. To translate that transcript into other languages while using Chrome, right click on the transcript, select “Translate to [language],” click the three dots next to the current language and select “Choose Another Language.” Select your preferred language in the dropdown list and click “Translate.”